135 related articles for article (PubMed ID: 7987974)
1. Human metabolism of the experimental cancer therapeutic agent d-limonene.
Crowell PL; Elson CE; Bailey HH; Elegbede A; Haag JD; Gould MN
Cancer Chemother Pharmacol; 1994; 35(1):31-7. PubMed ID: 7987974
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of perillic acid in humans after a single dose administration of a citrus preparation rich in d-limonene content.
Chow HH; Salazar D; Hakim IA
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1472-6. PubMed ID: 12433729
[TBL] [Abstract][Full Text] [Related]
3. Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee.
Vigushin DM; Poon GK; Boddy A; English J; Halbert GW; Pagonis C; Jarman M; Coombes RC
Cancer Chemother Pharmacol; 1998; 42(2):111-7. PubMed ID: 9654110
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of limonene metabolites in patients with advanced cancer by liquid chromatography/mass spectrometry.
Poon GK; Vigushin D; Griggs LJ; Rowlands MG; Coombes RC; Jarman M
Drug Metab Dispos; 1996 May; 24(5):565-71. PubMed ID: 8723738
[TBL] [Abstract][Full Text] [Related]
5. R-Limonene metabolism in humans and metabolite kinetics after oral administration.
Schmidt L; Göen T
Arch Toxicol; 2017 Mar; 91(3):1175-1185. PubMed ID: 27325307
[TBL] [Abstract][Full Text] [Related]
6. Identification of metabolites of the antitumor agent d-limonene capable of inhibiting protein isoprenylation and cell growth.
Crowell PL; Lin S; Vedejs E; Gould MN
Cancer Chemother Pharmacol; 1992; 31(3):205-12. PubMed ID: 1464157
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of protein prenylation by metabolites of limonene.
Hardcastle IR; Rowlands MG; Barber AM; Grimshaw RM; Mohan MK; Nutley BP; Jarman M
Biochem Pharmacol; 1999 Apr; 57(7):801-9. PubMed ID: 10075086
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of active drug metabolites after oral administration of perillyl alcohol, an investigational antineoplastic agent, to the dog.
Phillips LR; Malspeis L; Supko JG
Drug Metab Dispos; 1995 Jul; 23(7):676-80. PubMed ID: 7587953
[TBL] [Abstract][Full Text] [Related]
9. Gas chromatographic-mass spectrometric analysis of d-limonene in human plasma.
Wang S; Chen Y; Gao Z; Xiong M; Zhong Z; Ye L
J Pharm Biomed Anal; 2007 Sep; 44(5):1095-9. PubMed ID: 17540528
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of d-limonene in the rat by GC-MS assay.
Chen H; Chan KK; Budd T
J Pharm Biomed Anal; 1998 Aug; 17(4-5):631-40. PubMed ID: 9682146
[TBL] [Abstract][Full Text] [Related]
11. Bioequivalence evaluation of two D-limonene capsule formulations in healthy Chinese volunteers.
Liu T; Guo Y; Gao Z; Chen Z; Jiang X
Pharmazie; 2008 Oct; 63(10):718-20. PubMed ID: 18972832
[TBL] [Abstract][Full Text] [Related]
12. Gas chromatographic-mass spectrometric analysis of perillyl alcohol and metabolites in plasma.
Zhang Z; Chen H; Chan KK; Budd T; Ganapathi R
J Chromatogr B Biomed Sci Appl; 1999 May; 728(1):85-95. PubMed ID: 10379660
[TBL] [Abstract][Full Text] [Related]
13. Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies.
Hudes GR; Szarka CE; Adams A; Ranganathan S; McCauley RA; Weiner LM; Langer CJ; Litwin S; Yeslow G; Halberr T; Qian M; Gallo JM
Clin Cancer Res; 2000 Aug; 6(8):3071-80. PubMed ID: 10955786
[TBL] [Abstract][Full Text] [Related]
14. d-limonene exposure to humans by inhalation: uptake, distribution, elimination, and effects on the pulmonary function.
Falk-Filipsson A; Löf A; Hagberg M; Hjelm EW; Wang Z
J Toxicol Environ Health; 1993 Jan; 38(1):77-88. PubMed ID: 8421324
[TBL] [Abstract][Full Text] [Related]
15. The fate of dermally applied [14C]d-limonene in rats and humans.
Api AM; Ritacco G; Hawkins DR
Int J Toxicol; 2013; 32(2):130-5. PubMed ID: 23493903
[TBL] [Abstract][Full Text] [Related]
16. Distribution and immune responses resulting from oral administration of D-limonene in rats.
Hamada M; Uezu K; Matsushita J; Yamamoto S; Kishino Y
J Nutr Sci Vitaminol (Tokyo); 2002 Apr; 48(2):155-60. PubMed ID: 12171437
[TBL] [Abstract][Full Text] [Related]
17. Human breast tissue disposition and bioactivity of limonene in women with early-stage breast cancer.
Miller JA; Lang JE; Ley M; Nagle R; Hsu CH; Thompson PA; Cordova C; Waer A; Chow HH
Cancer Prev Res (Phila); 2013 Jun; 6(6):577-84. PubMed ID: 23554130
[TBL] [Abstract][Full Text] [Related]
18. Design of a gas chromatograph with parallel radioactivity and mass spectrometric detection. Application to the identification of the major metabolite of d-limonene associated with alpha 2u-globulin.
Rodriguez PA; Takigiku R; Lehman-McKeeman LD; Fey ML; Eddy CL; Caudill D
J Chromatogr; 1991 Feb; 563(2):271-82. PubMed ID: 1711535
[TBL] [Abstract][Full Text] [Related]
19. Anxiolytic-like activity and GC-MS analysis of (R)-(+)-limonene fragrance, a natural compound found in foods and plants.
Lima NG; De Sousa DP; Pimenta FC; Alves MF; De Souza FS; Macedo RO; Cardoso RB; de Morais LC; Melo Diniz Mde F; de Almeida RN
Pharmacol Biochem Behav; 2013 Jan; 103(3):450-4. PubMed ID: 22995322
[TBL] [Abstract][Full Text] [Related]
20. D-Limonene modulates T lymphocyte activity and viability.
Lappas CM; Lappas NT
Cell Immunol; 2012 Sep; 279(1):30-41. PubMed ID: 23059811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
